Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. J Surg Oncol 2020 May;121(6):975-983
Date
02/25/2020Pubmed ID
32090344DOI
10.1002/jso.25869Scopus ID
2-s2.0-85083530980 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Screening guidelines in patients with inherited endocrine syndromes and others at high risk for developing endocrine cancers have significant implications as early tumor detection is associated with improved outcomes. Given the unique challenges in diagnosis and treatment, patients at high risk for developing endocrine cancers require multidisciplinary care. The complexity of decision making and rarity of these syndromes support referral to high-volume centers with the experience and knowledge to treat these at-risk patients.
Author List
Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CNAuthors
Callisia N. Clarke MD Chief, Associate Professor in the Surgery department at Medical College of WisconsinDouglas B. Evans MD Professor in the Surgery department at Medical College of Wisconsin
Jennifer L. Geurts MS Director, Associate Professor in the Institute for Health and Humanity department at Medical College of Wisconsin
Tracy S. Wang MPH, MD Professor in the Surgery department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Carcinoma, Pancreatic DuctalEarly Detection of Cancer
Endocrine Gland Neoplasms
Humans
Multiple Endocrine Neoplasia
Pancreatic Neoplasms
Practice Guidelines as Topic
Thyroid Neoplasms
